Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from moglabs.bio, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Issues our data pipeline flagged on this vendor's COAs. Each flag points at a specific COA and the reason it was raised.
Lot "HCG002" appears on 2 vendors
COA labeled 1.00mg but archived vendor listing (igf-1-lr3 @ 2026-06-01) shows 10.00mg — 900% drift
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|
| BPC-157 | 1 | 98.35% | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| Retatrutide | RT1002 | Vanguard Laboratory | 99.80% | LALUSP<71> | — | View |
| NAD+ | NAD002 | Vanguard Laboratory | 98.59% | LALUSP<71> | — | View |
| Cagrilintide | CAG002 |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| BPC-157/TB-500 | 1 | 99.80% | — | — |
| Cagrilintide | 1 | 99.06% | — | — |
| CJC-1295 DAC | 1 | 99.84% | — | — | — |
| Dapoxetine | 1 | — | — | — | — |
| Dihexa | 1 | 99.46% | — | — |
| DSIP | 1 | 99.12% | — | — | — |
| GHK-Cu | 2 | 99.80% | — | — | — |
| GHRP-2 | 2 | 98.67% | — | — |
| GHRP-6 | 1 | 99.48% | — | — | — |
| GLOW 70mg | 1 | 99.78% | — | — |
| hCG | 1 | — | — | — | — |
| HCG | 1 | — | — | — | — | — |
| HGH Frag. 176-191 | 2 | 98.95% | — | — |
| IGF-1 LR3 | 1 | 98.64% | — | — |
| Ipamorelin | 3 | 99.84% | — | — |
| KPV | 1 | 99.80% | — | — |
| Melanotan I | 1 | 99.61% | — | — |
| Melanotan II | 1 | 99.14% | — | — |
| NAD+ | 1 | 98.59% | — | — | — |
| PEG MGF | 1 | 99.22% | — | — | — |
| PT-141 | 1 | 99.01% | — | — |
| Retatrutide | 1 | 99.80% | — | — | — |
| Selank | 1 | 99.66% | — |
| Semax | 1 | 98.75% | — | — |
| TB-500 (Tβ4) | 1 | 99.19% | — | — |
| Tesamorelin | 1 | 99.15% | — | — | — |
| Vanguard Laboratory |
| 99.06% |
| LALHM |
| — |
| View |
| PT-141 | PT402 | Vanguard Laboratory | 99.01% | LALUSP<71>HM | — | View |
| IGF-1 LR3 | IGF102 | Vanguard Laboratory | 98.64% | LALUSP<71>HM | — | View |
| KPV | KPV002 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-05-29 | View |
| Semax | SX002 | Chromate | 98.75% | LALHM | 2026-05-24 | View |
| TB-500 (Tβ4) | TB002 | Chromate | 99.19% | LALUSP<71>HM | 2026-05-24 | View |
| Ipamorelin | IPA002 | Vanguard Laboratory | 99.80% | LALUSP<71>HM | 2026-05-05 | View |
| BPC-157/TB-500 | BT002 | Vanguard Laboratory | 99.80% | LALHM | 2026-05-05 | View |
| Melanotan II | MT202 | Chromate | 99.14% | LALUSP<71>HM | 2026-04-22 | View |
| GLOW 70mg | GLO002 | Chromate | 99.78% | LALUSP<71>HM | 2026-04-22 | View |
| Melanotan I | MT102 | Chromate | 99.61% | LALUSP<71>HM | 2026-04-22 | View |
| Selank | SK002 | Chromate | 99.66% | MSLALUSP<71>HM | 2026-04-22 | View |
| HGH Frag. 176-191 | HGF001 | Vanguard Laboratory | 98.13% | LALUSP<71>HM | 2026-04-13 | View |
| GHRP-2 | GH202 | Vanguard Laboratory | 98.05% | LALUSP<71>HM | 2026-04-13 | View |
| hCG | HCG002 | Chromate | — | LALUSP<71>HM | 2026-03-29 | View |
| Dapoxetine | DAP001 | Chromate | — | HM | 2026-03-23 | View |
| Dihexa | DIH001 | Chromate | 99.46% | HM | 2026-03-23 | View |
| GHK-Cu | GHK102 | Chromate | 99.64% | LALUSP<71> | 2026-03-19 | View |
| GHK-Cu | GHK002 | Chromate | 99.97% | LALUSP<71> | 2026-03-19 | View |
| BPC-157 | BPC002 | Chromate | 98.35% | LALUSP<71>HM | 2026-03-18 | View |
| HCG | HCG002 | Vanguard Laboratory | — | LALUSP<71> | 2026-03-04 | View |
| CJC-1295 DAC | — | Janoshik Analytical | 99.84% | — | 2026-02-16 | View |
| MOD GRF (1-29) + Ipamorelin | — | Janoshik Analytical | — | — | 2026-02-16 | View |
| PEG MGF | — | Janoshik Analytical | 99.22% | — | 2026-02-13 | View |
| AOD-9604 | — | Janoshik Analytical | 99.77% | — | 2026-01-23 | View |
| Tesamorelin | — | Janoshik Analytical | 99.15% | — | 2026-01-21 | View |
| GHRP-6 | hg6001 | Janoshik Analytical | 99.48% | — | 2025-11-12 | View |
| GHRP-2 | hg2001 | Janoshik Analytical | 99.28% | — | 2025-11-12 | View |
| — | GBT001 | Janoshik Analytical | — | — | 2025-11-12 | View |
| DSIP | dsp001 | Janoshik Analytical | 99.12% | — | 2025-11-12 | View |
| Ipamorelin | ipa001 | Janoshik Analytical | 99.88% | — | 2025-11-12 | View |
Disclosed Labs